Semaglutide is mainly used to help manage blood sugar in adults with type 2 diabetes, but it is also commonly prescribed for weight loss and obesity management
While bowel obstruction is not established as a recognized adverse effect in FDA labeling or clinical trials, understanding the gastrointestinal risks, warning signs, and patient populations who should avoid tirzepatide is essential for safe prescribing and monitoring
Common adverse effects encountered by users The common side effects of semaglutide mainly affect the gastrointestinal tract, which can lead to acute kidney injury in some cases, as well as potential risk factors for diabetic retinopathy
For example, it gives you amino acids that are sulfur-bearing that carry that sulfur molecule that is important in producing glutathione
ASK-1, apoptosis signaling kinase-1
Like Qsymia, it is oral